• About
    • General information
    • Mission and values
    • History
    • Management
    • Cooperation
  • Production
    • Quality Management System
    • Production capacities
    • Manufacturing capabilities
  • Innovation
    • Avexima R&D Center
    • Departments
    • Technological Equipment
    • Analytical Equipment
  • Medicines
  • Press center
    • News
    • Press kit
  • Career
    • career
  • Contacts
  • +7 495 258-45-28
  • INFO@AVEXIMA.RU
back
  • News
  • Press kit

CARING FOR HEALTH - CREATING THE FUTURE!

News

The Irbit Chemical Pharmaceutical Plant celebrated a milestone anniversary - 80 years since the enterprise's founding

10 June 2022

The Irbit Chemical Pharmaceutical Plant celebrated a milestone anniversary - 80 years since the enterprise's founding

JSC Irbit Chemical Pharmaceutical Plant certified for Compliance with the Eurasian Economic Union Good Manufacturing Practice (EAEU GMP) Rules

21 April 2022

JSC Irbit Chemical Pharmaceutical Plant certified for Compliance with the Eurasian Economic Union Good Manufacturing Practice (EAEU GMP) Rules

Avexima and FC Grand Capital Explore the Possibility of Drug Development on Russky Island

28 March 2022

Avexima and FC Grand Capital Explore the Possibility of Drug Development on Russky Island

Pharmaceutical company Avexima and national pharmaceutical distributor FC Grand Capital to more than double investments in the Moscow Region

9 December 2021

Pharmaceutical company Avexima and national pharmaceutical distributor FC Grand Capital to more than double investments in the Moscow Region

Avexima Signs Cooperation Agreement with the Russky Innovation Center Development Fund at EEF 2021

3 September 2021

Avexima Signs Cooperation Agreement with the Russky Innovation Center Development Fund at EEF 2021

JSC Avexima Participates in the International Military-Technical Forum «ARMY-2021»

28 August 2021

JSC Avexima Participates in the International Military-Technical Forum «ARMY-2021»

  • 5
  • 6
  • 7
  • 8
  • 9

Shown 42 from 71 news

Press kit

Logos

Avexima logo Avexima logo (png 45.11 Kb)

Documents

Company information Company information (pdf 210.17 Kb)

© 2011—2026 JSC Avexima.
All rights of the website are reserved

Personal Data Processing Policy

Avexima invites pharmaceutical distributors and pharmacy chains to cooperate. We will be happy to answer all your questions by phone or e-mail:

  • +7 495 258-45-28
  • INFO@AVEXIMA.RU
  • 31A LENINGRADSKY PROSPEKT, BLDG. 1, MOSCOW, 125284, RUSSIA

Applicant's profile

Desired Area *

Attach your resume
Maximum file size 5 MB

Provide information on the safety of the drug (for the patient)

1000

stage 1/5

Report
an undesirable reaction

Sender Information

Patient Information

Information about the suspected drug

Description of the event related to the safety and efficacy of the drug

Additional information

Gestation period in weeks
years
  • years
  • month
  • days
Characters left: 300
Characters left: 300
Characters left: 300
Characters left: 300
Characters left: 1000
Characters left: 300
Characters left: 300
Characters left: 300

Criteria for the severity of an adverse reaction

Outcome

Characters left: 1000
Characters left: 500

Attach files (for example, test results, discharge, doctor's report, etc.) Files should not be larger than 5 MB

Medical Information Request Form

You

Preferred way to receive a response

Leave a request about the quality of the drug

The person reporting a problem with the quality of the medicinal product
Information about the medicinal product and the essence of the treatment

Photos showing a problem with the quality of the drug, including photos with the batch number of the drug

The website uses cookies to personalize user services. By continuing to use the website, you agree to the Cookie Policy and consent to the processing of personal data by Avexima OJSC (31a Leningradsky Ave., building 1, 125284, Moscow). You can disable the storage of cookies in your browser settings.

accept and close